Singhal Priya 4
4 · BIOGEN INC. · Filed Feb 10, 2026
Research Summary
AI-generated summary of this filing
Biogen (BIIB) Head of Development Priya Singhal Sells Shares After RSU Conversion
What Happened
Priya Singhal, Head of Development at Biogen (BIIB), had restricted/derivative awards convert into common shares on Feb 6, 2026 (totaling 6,900 shares from two conversions: 2,217 and 4,683). Of those converted shares, 2,468 shares (1,056 + 1,412) were surrendered to cover tax liabilities (payment value reported at $201.18 per share, totaling $496,512). On Feb 9, 2026 she sold 2,660 shares in an open-market transaction at $199.83 per share for $531,548. After the conversions, withholding and the sale, roughly 1,772 shares from this conversion event remain (6,900 converted − 2,468 withheld − 2,660 sold = 1,772), though the filing does not state total company shares she owns post-transaction.
Key Details
- Transaction dates and prices:
- Feb 6, 2026: Conversion/exercise of derivatives/RSUs — 2,217 and 4,683 shares (acquired via conversion; $0 exercise price reported).
- Feb 6, 2026: Tax withholding — 1,056 shares and 1,412 shares withheld at $201.18 (total ~$496,512).
- Feb 9, 2026: Open-market sale — 2,660 shares at $199.83, proceeds $531,548.
- Nature of transactions: M = exercise/conversion of derivative (RSU conversion), F = shares surrendered to pay tax liability, S = open-market sale.
- Footnotes:
- F1: One grant vests in three equal annual installments beginning 02/07/2024.
- F2: Another grant vests in three equal annual installments beginning 02/06/2025.
- Shares owned after transaction: The filing does not state total holdings; approximately 1,772 shares from this conversion event remain un-surrendered/un-sold.
- Filing timeliness: Report filed 2026-02-10 covering transactions on 2026-02-06; the filing does not indicate a late report.
Context
These entries reflect RSU/derivative conversions and routine tax withholding rather than an out-of-pocket purchase. The sequence — conversion, withholding of shares for taxes, then an open-market sale — is common when equity awards vest (a form of cashless settlement). Such sales are often administrative (to cover taxes or diversify) and are not, by themselves, a clear signal of a change in insider sentiment.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-06+2,217→ 8,488.143 total - Tax Payment
Common Stock
2026-02-06$201.18/sh−1,056$212,446→ 7,432.143 total - Exercise/Conversion
Common Stock
2026-02-06+4,683→ 12,115.143 total - Tax Payment
Common Stock
2026-02-06$201.18/sh−1,412$284,066→ 10,703.143 total - Sale
Common Stock
2026-02-09$199.83/sh−2,660$531,548→ 8,043.143 total - Exercise/Conversion
Restricted Stock Unit
[F1]2026-02-06−2,217→ 2,217 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (2,217 underlying) - Exercise/Conversion
Restricted Stock Unit
[F2]2026-02-06−4,683→ 9,367 totalExercise: $0.00Exp: 2028-02-06→ Common Stock (4,683 underlying)
Footnotes (2)
- [F1]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
- [F2]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.